Genomics to make treatment recommendations for recurrent glioblastoma patients
Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient’s tumour to inform treatment for these patients in real-time. The study was led by the Translational Genomics Research Institute (TGen), UC […]
